or
forgot password

    • cancer clinical trials in massachusetts

    • SU011248 in Advanced Hepatocellular Carcinoma
    Beth Israel Deaconess Medical Center

    Trial Locations
    Beth Israel Deaconess Medical Center
    Dana-Farber Cancer Institute
    Massachusetts General Hospital
    Hepatocellular Carcinoma, Liver Cancer
    Bevacizumab, Radiation Therapy, and Cisplatin in Treating Patients With Previously Untreated Locally Advanced Cervical Cancer
    Boston Medical Center

    Trial Locations
    Boston Medical Center
    Brigham and Women's Hospital
    Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Squamous Cell Carcinoma, Stage IB Cervical Cancer, Stage IIA Cervical Cancer, Stage IIB Cervical Cancer, Stage III Cervical Cancer
    Combination Chemotherapy With or Without Gemtuzumab in Treating Young Patients With Newly Diagnosed Acute Myeloid Leukemia
    Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute

    Trial Locations
    Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute
    Floating Hospital for Children at Tufts - New England Medical Center
    Massachusetts General Hospital
    Baystate Regional Cancer Program at D'Amour Center for Cancer Care
    UMASS Memorial Cancer Center - University Campus
    Leukemia
    Laboratory-Treated Peripheral Blood Cell Infusion After Donor Stem Cell Transplant in Treating Patients With Hematologic Cancers or Other Diseases
    Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute

    Trial Locations
    Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute
    Massachusetts General Hospital
    Children's Hospital Boston
    Leukemia, Myelodysplastic Syndromes
    Stereotactic Radiation Therapy With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases
    Lowell General Hospital

    Trial Locations
    Lowell General Hospital
    Saint Vincent Hospital at Worcester Medical Center
    Breast Cancer, Cognitive/Functional Effects, Lung Cancer, Metastatic Cancer, Prostate Cancer
    Bortezomib, Lenalidomide and Dexamethasone Combination Therapy in Patients With Newly Diagnosed Multiple Myeloma
    Massachusetts General Hospital
    Boston, Massachusetts 02114-2617
    Multiple Myeloma
    Bortezomib, Lenalidomide, and Dexamethasone Combination Therapy for Patients With Relapsed or Relapsed and Refractory Multiple Myeloma
    Dana-Farber Cancer Institute

    Trial Locations
    Dana-Farber Cancer Institute
    Massachusetts General Hospital
    Multiple Myeloma
    Tandutinib in Treating Patients With Recurrent or Progressive Glioblastoma
    Dana-Farber Cancer Institute

    Trial Locations
    Dana-Farber Cancer Institute
    Massachusetts General Hospital
    Adult Brain Tumor, Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, Recurrent Adult Brain Tumor
    Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor
    Floating Hospital for Children at Tufts Medical Center

    Trial Locations
    Floating Hospital for Children at Tufts Medical Center
    University of Massachusetts Medical School
    Stage III Wilms Tumor, Stage IV Wilms Tumor
    Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
    Dana-Farber/Brigham and Women's Cancer Center

    Trial Locations
    Dana-Farber/Brigham and Women's Cancer Center
    Lahey Clinic Medical Center - Burlington
    South Shore Hospital
    Baystate Regional Cancer Program at D'Amour Center for Cancer Care
    Esophageal Cancer
    Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer
    Tufts-NEMC Cancer Center

    Trial Locations
    Tufts-NEMC Cancer Center
    Boston University Cancer Research Center
    Lahey Clinic Medical Center - Burlington
    Commonwealth Hematology-Oncology, PC - Concord
    Commonwealth Hematology Oncology PC - Dorchester
    Hudner Oncology Center at Saint Anne's Hospital - Fall River
    Simonds-Sinon Regional Cancer Center at HealthAlliance Hospital - Burbank Campus
    Addison Gilbert Hospital
    Commonwealth Hematology-Oncology, PC - Lawrence
    Commonwealth Hematology Oncology PC - Leominster
    Caritas Holy Family Hospital
    NSMC Cancer Center - Peabody
    Berkshire Hematology Oncology, PC
    Jordan Hospital Club Cancer Center
    Commonwealth Hematology-Oncology, PC - Quincy
    Baystate Regional Cancer Program at D'Amour Center for Cancer Care
    Commonwealth Hematology-Oncology, PC - Stoneham
    Commonwealth Hematology-Oncology, PC - Weymouth
    UMASS Memorial Cancer Center - University Campus
    Commonwealth Hematology-Oncology, PC - Worcester
    Breast Cancer
    Fulvestrant With or Without Lapatinib in Treating Postmenopausal Women With Stage III or Stage IV Breast Cancer That is Hormone Receptor-Positive
    Beth Israel Deaconess Medical Center

    Trial Locations
    Beth Israel Deaconess Medical Center
    Dana-Farber Cancer Institute
    Brigham and Women's Hospital
    Lowell General Hospital
    Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor
    Floating Hospital for Children at Tufts Medical Center
    Boston, Massachusetts 02111
    Untreated Childhood Medulloblastoma, Untreated Childhood Pineoblastoma, Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor
    Bevacizumab/Tarceva and Tarceva/Sulindac in Squamous Cell Carcinoma of the Head and Neck
    Dana-Farber Cancer Institute
    Boston, Massachusetts 02115
    Squamous Cell Carcinoma of the Head and Neck (SCCHN)